Page last updated: 2024-10-30

lansoprazole and Cronobacter Infections

lansoprazole has been researched along with Cronobacter Infections in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research Excerpts

ExcerptRelevanceReference
"Colitis was induced with less C."1.48Proton Pump Inhibitors Increase the Susceptibility of Mice to Oral Infection with Enteropathogenic Bacteria. ( Adachi, S; Azuma, T; Fukuda, S; Hoshi, N; Inoue, J; Ishida, T; Kong, L; Ku, Y; Ooi, M; Otsuka, T; Tsukimi, T; Watanabe, D; Yamairi, H; Yasutomi, E; Yoshida, M, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yasutomi, E1
Hoshi, N1
Adachi, S1
Otsuka, T1
Kong, L1
Ku, Y1
Yamairi, H1
Inoue, J1
Ishida, T1
Watanabe, D1
Ooi, M1
Yoshida, M1
Tsukimi, T1
Fukuda, S1
Azuma, T1

Other Studies

1 other study available for lansoprazole and Cronobacter Infections

ArticleYear
Proton Pump Inhibitors Increase the Susceptibility of Mice to Oral Infection with Enteropathogenic Bacteria.
    Digestive diseases and sciences, 2018, Volume: 63, Issue:4

    Topics: Animals; Citrobacter rodentium; Colitis; Disease Models, Animal; Enterobacteriaceae Infections; Lans

2018